Glecaprevir and Pibrentasvir
3 NDCs across 1 manufacturer|0 Generic,3 Brand
▸ More about this market▾ Less
Glecaprevir and Pibrentasvir is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $152.98 to $152.98 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$152.98 – $152.98
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
AbbVie Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis C Virus NS3/4A Protease Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GLECAPREVIR AND PIBRENTASVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MAVYRET 100-40 MG TABLET | $152.9834 per EA | +0.04% |
MAVYRET 100-40 MG TABLET | $152.9834 per EA | +0.04% |
MAVYRET 100-40 MG TABLET | $152.9834 per EA | +0.04% |
Frequently Asked Questions
How many Glecaprevir and Pibrentasvir products are on the market?
The Glecaprevir and Pibrentasvir drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Glecaprevir and Pibrentasvir?
NADAC reference prices for Glecaprevir and Pibrentasvir range from $152.9834 to $152.9834 per EA.
Which manufacturers make Glecaprevir and Pibrentasvir?
1 manufacturer lists Glecaprevir and Pibrentasvir in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (3).
How has the price of Glecaprevir and Pibrentasvir changed recently?
Over the past 7 days, 6 Glecaprevir and Pibrentasvir NDCs rose and 0 fell, with a market-wide average change of +0.0%.